Vanguard FTSE Developed Europe UCITS ETF (GBP) | VEURRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -2.6 | 25.2 | -10.0 | 16.5 | 2.1 | |
+/-Cat | -6.9 | 9.9 | -1.7 | 4.9 | -0.1 | |
+/-B’mrk | -5.1 | 7.6 | -5.4 | 3.3 | -0.2 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 27/03/2024 | GBX 3393.50 | |
Day Change | 0.06% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 20591 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00B945VV12 | |
Fund Size (Mil) 27/03/2024 | EUR 3570.90 | |
Share Class Size (Mil) 27/03/2024 | EUR 2809.40 | |
Ongoing Charge 17/02/2023 | 0.10% |
Morningstar Research |
Investment Objective: Vanguard FTSE Developed Europe UCITS ETF (GBP) | VEUR |
This Fund seeks to track the performance of the Index, a widely recognised benchmark a of stock market performance of European developed countries that is comprised of the stocks of large and mid cap sized companies in developed Europe. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 21/05/2013 | ||
Inception Date 21/05/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE Developed Europe TR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Vanguard FTSE Developed Europe UCITS ETF (GBP) | VEUR | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.39 |
ASML Holding NV | Technology | 3.38 |
Nestle SA | Consumer Defensive | 2.53 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 2.05 |
Novartis AG Registered Shares | Healthcare | 1.91 |
Increase Decrease New since last portfolio | ||
Vanguard FTSE Developed Europe UCITS ETF (GBP) | VEUR |